Worldwide, infections with influenza A viruses are associated with substantial illness and death among mammals and birds. Public health and research have placed major focus on understanding the pathogenicity of different influenza virus strains and characterizing new influenza vaccines. Nonhuman primates (NHPs), including macaques, have become popular experimental models for studying the pathogenesis and immunology of seasonal and emerging influenza viruses. NHPs readily seroconvert after experimental inoculation with seasonal influenza virus and have been used to test candidate vaccines for strains of human and avian origin. Like humans, macaques infected with influenza virus exhibit fever, malaise, nasal discharge, and nonproductive cough; virus replication can be detected in the nasal passages and respiratory tract ([@R1],[@R2]). However, whether NHPs are infected with influenza viruses in nature remains unknown.

Over the past decade, we have focused on the role of pet and performing monkeys in disease transmission throughout Asia. Commonly trapped in the wild, these monkeys might be sold at wet markets, the putative source of several zoonotic outbreaks ([@R3]), where they might be caged next to any number of animal species ([Figure 1](#F1){ref-type="fig"}, panel A) ([@R4]). Pet and performing monkeys are likely conduits for cross-species transmission of respiratory pathogens like influenza viruses because of their close and long-term contact with their owners, audiences, domestic animals, wild animals, and birds ([Figure 1](#F1){ref-type="fig"}, panel B) ([@R5]). However, the breadth and diversity of this interface presents a challenge for monitoring the emergence of infectious diseases. We have approached this challenge by conducting longitudinal studies at several sites and collecting biological samples and behavioral data representing various contexts of human--NHP contact ([@R4]--[@R7]). We used these historical and newly acquired samples, representing various countries and contexts of human--macaque contact, to determine whether NHPs are infected with influenza viruses in nature.

![The interface between nonhuman primates, birds, and humans. A) A young, recently captured leaf monkey perched on a cage containing birds in a wet market in Java. B) A man and his performing monkey in Bangladesh. Reprinted with permission from Lynn Johnson, 2012.](12-0214-F1){#F1}

The Study
=========

As part of our decade-long longitudinal studies, ≈200 serum samples were collected from macaques. These included pet macaques (*Macaca nigra, M. nigrescens, M. hecki*) from Sulawesi, Indonesia; performing macaques from Java, Indonesia (*M. fascicularis*) and from Bangladesh (*M. mulatta*); *M. fascicularis* macaques from the Bukit Timah and Central Catchment Nature Reserves in Singapore, where they freely interact with wild avian fauna and visitors (occasionally entering residential areas) ([@R7]); *M. sylvanus* macaques from the Upper Rock Nature Reserve in Gibraltar, where international tourists frequently use food to entice the macaques to climb about their heads and shoulders ([@R6]); and free-ranging macaques (*M. fascicularis* and *M. nemestrina*) at temple shrines or *M. fascicularis* macaques that range throughout a wildlife rescue center and nearby villages in Cambodia ([Figure 2](#F2){ref-type="fig"}). Serum was collected and stored as described ([@R8]). All samples were stored on cold packs in the field and transferred to dry ice for shipment to the United States, where they were then stored at −80°C.

![Nonhuman primate (NHP) habitat countries (in green) and approximate location of sampling sites, with sample size, year collected, context of human--macaque interaction, and seroprevalence of antibodies against influenza virus A. Countries that have reported human influenza infection of avian origin (AI) are outlined in purple.](12-0214-F2){#F2}

For initial screening for antibodies against influenza virus, serum samples were treated with receptor-destroying enzyme as described ([@R9]) and tested by using a multispecies Influenza A Virus NP Antibody Inhibition Test (Virusys Corporation, Taneytown, MD, USA) according to manufacturer's instructions. ELISA results indicated nucleocapsid protein antibodies against influenza in samples from macaques from Cambodia (29.2%), Singapore (16.7%), Sulawesi (16.1%), Bangladesh (13.3%), and Java (6.0%) ([Table 1](#T1){ref-type="table"}). Antibodies were detected in animals 1--10 years of age at the time of sampling. No influenza virus--specific antibodies were detected from the 73 total samples from Gibraltar, perhaps because persons with influenza virus infection infrequently travel to the Upper Rock Reserve (healthy-visitor effect) ([@R10]) or perhaps because monkeys from Gibraltar are less susceptible to infection. Seroprevalence of antibodies against influenza A, by site and collection year, human and NHP population densities, and prevalence of avian influenza viruses are shown in [Figure 2](#F2){ref-type="fig"}.

###### Anti-influenza nucleocapsid protein antibodies in nonhuman primate populations, 2001--2011\*

  Location, year    No.   *Macaca* species                 Type(s)                  No. (%) positive
  ----------------- ----- -------------------------------- ------------------------ ------------------
  Singapore, 2003   36    *fascicularis*                   Reserve                  6 (16.7)
  Indonesia                                                                         
  Java, 2002        14    *fascicularis*                   Performing, pet          4 (28.6)
  Sulawesi, 2001    31    *nigra*, *hecki*, *nigrescens*   Pet                      5 (16.1)
  Gibraltar                                                                         
  2005              37    *sylvanus*                       Reserve                  0
  2009              36    *sylvanus*                       Reserve                  0
  Bangladesh                                                                        
  2006              4     *mulatta*                        Performing, pet          0
  2010              30    *mulatta*                        Performing, pet          4 (13.3)
  Cambodia, 2011    48    *fascicularis, nemestrina*       Temple, urban, reserve   14 (29.2)

\*Testing was conducted with a multispecies influenza A virus nucleocapsid protein antibody inhibition test for strain-specific antibodies.

Serum samples that were positive by ELISA were also screened by hemagglutination-inhibition assay as described ([@R9]). Based on the year and location of NHP sample collection, the estimated ages of the NHPs at the time of sample collection, and the presence of avian H5 and H9 influenza viruses in many of these countries during the sampling period ([@R11]--[@R13]), a panel of human vaccine strains and avian influenza virus strains was used in the hemagglutination-inhibition assay. Although not all ELISA-positive serum samples could be subtyped, antibodies against seasonal subtype H1N1 and H3N2 influenza A strains were detected from macaques in Bangladesh, Singapore, Java, and Sulawesi ([Table 2](#T2){ref-type="table"}). Of the performing macaques in Bangladesh, 2 had antibodies against A/chicken/Bangladesh/5473/2010, a strain of G1 clade subtype H9N2 avian influenza virus. Subtype H9N2 influenza viruses are prevalent in poultry in Bangladesh ([@R14]) and have been detected in humans ([@R12]). We did not detect antibodies against highly pathogenic avian influenza subtype H5 viruses, which might not be surprising given our relatively small sample size ([Table 2](#T2){ref-type="table"}). Also given the small sample size, we were unable to perform microneutralization studies, which would be useful to perform with future samples.

###### Seroprevalence of influenza A virus subtypes in monkeys with nucleocapsid protein--positive ELISAs, by location\*

  Virus strain                     Virus subtype (H5 clade)   Years used in vaccine   No. tested/no. positive                      
  -------------------------------- -------------------------- ----------------------- ------------------------- ----- ------ ----- ------
  A/Beijing/262/1995               H1N1                       1999--2000              0/6                       2/4   1/6†   NSA   NSA
  A/Sydney/5/1997                  H3N2                       1999--2000              2/6‡                      0/4   1/6§   NSA   NSA
  A/New Caledonia/20/1999          H1N1                       2000--2007              0/6                       0/4   1/6†   0/4   0/14
  A/Panama/2007/1999               H3N2                       2000--2004              2/6‡                      0/4   1/6§   0/4   NSA
  A/California/07/2004             H3N2                       2005--2006              NSA                       NSA   NSA    0/4   0/14
  A/Wisconsin/67/2005              H3N2                       2006--2008              NSA                       NSA   NSA    0/4   0/14
  A/Brisbane/59/2007               H1N1                       2008--2010              NSA                       NSA   NSA    1/4   0/14
  A/Brisbane/10/2007               H3N2                       2008--2010              NSA                       NSA   NSA    0/4   0/14
  A/California/04/2009             H1N1                       2010--present           NSA                       NSA   NSA    0/4   0/14
  A/Perth/16/2009                  H3N2                       2010--present           NSA                       NSA   NSA    0/4   0/14
  A/chicken/Bangladesh/5473/2010   H9 G1                      NA                      NSA                       NSA   NSA    2/4   NSA
  A/Vietnam/1203/2004              H5 (1)                     NA                      NSA                       NSA   NSA    NSA   0/14
  A/Cambodia/R0H05050/2007         H5 (1)                     NA                      NSA                       NSA   NSA    NSA   0/14
  A/duck/Hunan/795/2002            H5 (2.1)                   NA                      NSA                       NSA   NSA    0/4   NSA
  A/BHG/Qinghai/01/2005            H5 (2.2.2)                 NA                      NSA                       NSA   NSA    0/4   NSA
  A/JWE/Hong Kong/1038/2006        H5 (2.3.4.2)               NA                      NSA                       NSA   NSA    0/4   NSA
  A/duck/Laos/3295/2006            H5 (2.3.4.2)               NA                      NSA                       NSA   NSA    0/4   NSA

\*Samples were only tested for relevant strains based on the collection location, year of collection, and estimated age of the monkey. Monkeys from Indonesia were not tested for influenza subtype H5N1 viruses because samples were collected in 2001 and 2002 and subtype H5N1 viruses were first reported in poultry from Indonesia in February 2004. Samples with a hemagglutination inhibition value ≥1:10 were considered positive. NSA, no samples available for testing; NA, not applicable for use in vaccine; BHG, bar-headed goose; JWE, Japanese white-eye. †Individual monkey gave positive results for both strains. ‡Individual monkeys gave positive results for both strains. §Individual monkey gave positive results for both strains.

In 2011, to determine whether any macaques were actively infected with influenza virus, we collected oral swabs from 48 monkeys in Cambodia to test for influenza virus by real-time reverse transcription PCR as described ([@R8]). In brief, the inside of the anesthetized and immobilized monkeys' mouths (cheeks, tongue, and gums) were swabbed. Swabs were immediately placed into viral transport media, stored, and shipped as previously described. RNA was isolated by using an Ambion MagMAX-96 AI/ND Viral RNA Isolation Kit (Life Technologies Corporation, Grand Island, NY, USA) on a Kingfisher Flex system (Thermo Fisher Scientific, Waltham, MA, USA). Viral RNA was analyzed in a Bio-Rad CFX96 Real-Time PCR Detection System and a C1000 Thermocycler (Bio-Rad, Hercules, CA, USA) with TaqMan Fast Virus 1-Step Master Mix (Applied Biosystems, Foster City, CA, USA) and the InfA primer/probe sets as described ([@R15]). Of the 48 respiratory samples, 1 (2.1%) was positive for influenza virus; cycle threshold value was 38 (limit of detection is 40). Attempts to amplify longer PCR fragments of matrix, hemagglutinin, or neuraminidase genes or to isolate the virus by blind passage in embryonated chicken eggs or MDCK cells were unsuccessful.

Conclusions
===========

Our results indicate that NHPs that have contact with humans can be naturally infected with seasonal endemic human influenza viruses and with emerging pandemic-risk avian influenza viruses. We found serologic evidence of infection in several countries, contexts, and macaque species. Preliminary real-time reverse transcription PCR results also pointed to the presence of virus in a buccal swab from an adult macaque from Cambodia, indicating active infection at the time of sampling. On the basis of results from this study, it seems that pet, performing, and free-ranging macaques are susceptible to influenza virus infection. Given the close relationship between humans and NHPs in areas of the world where avian and human influenza viruses cocirculate, further surveillance of these populations is warranted. The ability to detect and eventually isolate strains of influenza virus currently infecting NHPs and humans at the animal--human interface is paramount to understanding how NHP--human interactions can affect the genetics, transmission, and public health risk for infection with influenza A viruses.
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